RELATIONSHIP OF METABOLIC PARAMETERS AND VASCULAR REMODELLING IN COMORBIDITY OF ESSENTIAL HYPERTENSION, TYPE 2 DIABETES AND OBESITY
DOI:
https://doi.org/10.21856/j-PEP.2016.4.02Keywords:
essential hypertension, type 2 diabetes, obesity, vascular remodelingAbstract
The aim of the study was to assess the relationship of metabolic parameters and vascular remodeling in patients with comorbidity of essential hypertension (EH), type 2 diabetes and obesity. We were examined 320 patients with EH stage II, grade 2 and type 2 diabetes moderate, subcompensated; 90 patients with EH stage II, grade 2 without type 2 diabetes and 31 healthy individuals. It was found that in comorbidity of EH, type 2 diabetes and obesity lipid and carbohydrate disorders, levels of adipokines and cytokines are linked and are the basis for the progression of the disease and for the beginning of cardiovascular complications, which was confirmed by data of correlation and variance analysis.
References
Sirenko JuN. Gipertonicheskaja bolezn’ i arterial’nye gipertenzii, Kiev, 2011: 287 p.
Zanchetti A. J Hypertens 2014; 32(3):451-453. doi: http://dx.doi.org/10.1097/HJH.0000000000000116
Bo S, Gambino R, Gentile L, et al. J Hypertens 2009; 27(1):102-108. doi: http://dx.doi.org/10.1097/HJH.0b013e328317a7bb
Bratus’ VV, Talaeva TV, Shumakov VA. Ozhirenie, insulinorezistentnost’, metabolicheskij sindrom: fundamental’nye i klinicheskie aspekty, Kiev, 2009: 416 p.
Dedov II, Mel’nichenko GA. Ozhirenie: jetiologija, patogenez, klinicheskie aspekty, Moskva, 2006: 456 p.
Yaghootkar H, Scott RA, White CC, et al. Diabetes 2014; 63(12):4369-4377. doi: http://dx.doi.org/10.2337/db14-0318
Henry SL, Barzel B, Wood-Bradley RJ, et al. Clin Exp Pharmacol Physiol 2012; 39(9):799-806. doi: http://dx.doi.org/10.1111/j.1440-1681.2011.05579.x
Jensen MD. Eur Heart J 2006; 8(Suppl B):B13-B19.
Lobato NS, Filgueira FP, Akamine EH, et al. Braz J Med Biol Res 2012; 45(5):392-400. doi: http://dx.doi.org/10.1590/S0100-879X2012007500058
Deussen A, Ohanyan V, Jannasch A. J Mol Cell Cardiol 2012; 52(4):794-801. doi: http://dx.doi.org/10.1016/j.yjmcc.2011.10.001
Tzotzas T, Evangelou P, Kiortsis DN. Obesity Rev 2011; 12(5):e282-e289. doi: http://dx.doi.org/10.1111/j.1467-789X.2010.00807.x
Herrmann J, Kaski JC, Lerman A. Eur Heart J 2012; 33:2771-2783. doi: http://dx.doi.org/10.1093/eurheartj/ehs246
Shah S, Casas JP, Gaunt TR, et al. Eur Heart J 2013; 34(13):972-981. doi: http://dx.doi.org/10.1093/eurheartj/ehs243
Lyons TJ, Basu A. Translational Res 2012; 159(4):303-312. doi: http://dx.doi.org/10.1016/j.trsl.2012.01.009